latest
We explore how legacy infrastructure, siloed incentives, and risk-averse culture block scale every time.
Every week, someone in the NHS or wider care system launches a promising innovation. A new tool. A better workflow. A clever tweak to triage, discharge, or prescribing.
And for a while, it works.
It solves a problem in one service, improves outcomes for one patient group, or creates new energy in one local team. It is heralded as a break throughout. Then comes the harder question: can it scale?
That’s where most innovation efforts stall.
It’s not because the idea is weak or the need isn’t real, it’s because the system it sits in hasn’t changed.
We talk a lot about spread and scale in healthcare innovation but far less about why it so often fails.
The answer isn’t always about cost or complexity. Often, it’s structural. Systemic. Cultural.
Being blunt: you can’t graft new ideas onto broken foundations and expect them to thrive.
So, what gets in the way?
1. Legacy Infrastructure
From ageing IT systems to outdated estates, legacy infrastructure limits what’s possible. New innovations often rely on interoperability, flexibility, or real-time data but they’re deployed into environments not designed to support them.
It’s like trying to stream high-definition video through a dial-up connection. No matter how good the content is, the system can’t handle it.
2. Siloed Incentives
In the NHS, teams are often rewarded for protecting their patch not for collaborating across it. Budgets are held in different pots. Success is measured differently across organisations.
So even when an innovation could be shared, there’s no clear incentive – or operational mechanism – to make it happen.
3. Risk-Averse Culture
Innovation requires experimentation. But in risk-averse environments – where mistakes are punished, scrutiny is high, and resources are tight – there’s little appetite for trial and error.
Add in the fear of reputational damage or regulatory fallout, and scaling becomes something to survive, not embrace.
Take the example of delayed discharge.
Innovations here have included everything from real-time dashboards to rapid-response care packages. In isolated pilots, they’ve shown impact: freeing up beds, improving patient flow, reducing emergency readmissions.
But when attempts are made to scale these solutions across an entire ICS or region, progress often grinds to a halt.
Why?
In other words, the innovation moved, but the system didn’t.
If we want innovation to go further than the pilot site, we have to do more than fund the tool. We have to shift the context it sits in.
That means changing:
1. From Adoption to Adaptation
Scaling isn’t copy-and-paste. It’s about adapting innovations to new contexts – each with their own cultures, constraints, and configurations.
This requires local co-design, flexibility in delivery, and space for variation – not rigid playbooks.
Innovation teams need to stop asking, “How do we roll this out?” and start asking, “How do we make this fit?”
2. From Outputs to Infrastructure
Scaling isn’t just a delivery issue. It’s an infrastructure issue.
Key questions may include – Are there mechanisms for shared procurement across partners? Is there headroom in staff workloads to train, embed, and adjust? Who owns the scaling process?
We need to stop treating innovation as something separate from the system and start seeing it as something that only succeeds through the system.
3. From Hero Innovators to Shared Ownership
Most pilots rely on a small group of committed individuals pushing against the grain. But when scaling relies on heroes, it rarely lasts.
We need structures of ownership, not just moments of inspiration. That includes clear governance, cross-organisational alignment, and resourcing that reflects complexity not just ambition.
In many NHS programmes, there’s a rush to scale before readiness. Success is often defined as “how many sites are using it” rather than “how deeply has this changed outcomes, behaviours, or systems.”
This creates a trap:
We’ve seen this pattern too many times. And the result is innovation fatigue – a sense that “we’ve tried this before” even when the root issue wasn’t the idea, but the readiness of the system around it.
At Future Care Capital, we’ve worked on scaling system interventions across the NHS and wider care sector. What we’ve learned is simple:
Scaling must be designed from the start.
That means:
If scale is the goal, the foundation matters more than the feature list.
While others tend to focus on what is being scaled: a tool, a practice, a programme.
We support the need to scale is the system that supports it.
That includes:
Without these, even the best innovations can’t take root beyond their original context.
If you’ve ever wondered why a pilot worked brilliantly in one place and fell flat somewhere else, the answer usually lies in the system, not the solution.
Scaling innovation in the NHS isn’t about force-fitting good ideas into unready systems.
It’s about changing the system so that good ideas can grow.
At Future Care Capital, we work with partners across health and care to do just that – building the relationships, governance, and learning infrastructure that allow innovation not just to succeed, but to scale.
Because unless the system changes, the innovation won’t last.
If you want to talk to us about how we do this, then get in touch lauren@futurecarecapital.org.uk